120 related articles for article (PubMed ID: 2323837)
1. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS.
Dias P; Kumar P; Marsden HB; Gattamaneni HR; Heighway J; Kumar S
Int J Cancer; 1990 Apr; 45(4):593-6. PubMed ID: 2323837
[TBL] [Abstract][Full Text] [Related]
2. MYCN gene amplification in rhabdomyosarcoma.
Driman D; Thorner PS; Greenberg ML; Chilton-MacNeill S; Squire J
Cancer; 1994 Apr; 73(8):2231-7. PubMed ID: 8156531
[TBL] [Abstract][Full Text] [Related]
3. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
[TBL] [Abstract][Full Text] [Related]
4. Amplification of N-myc in a rhabdomyosarcoma.
Mitani K; Kurosawa H; Suzuki A; Hayashi Y; Hanada R; Yamamoto K; Komatsu A; Kobayashi N; Nakagome Y; Yamada M
Jpn J Cancer Res; 1986 Nov; 77(11):1062-5. PubMed ID: 2432051
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
Taylor SR; Locker J
Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
[TBL] [Abstract][Full Text] [Related]
7. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis.
Kilpatrick SE; Teot LA; Geisinger KR; Martin PL; Shumate DK; Zbieranski N; Russell GB; Fletcher CD
Cancer; 1994 Dec; 74(12):3227-33. PubMed ID: 7526971
[TBL] [Abstract][Full Text] [Related]
8. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
Maillet MW; Robinson RA; Burgart LJ
Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
[TBL] [Abstract][Full Text] [Related]
10. Gene alterations and apoptosis in rhabdomyosarcoma.
Boman F; Brel D; Antunes L; Alhamany Z; Floquet J; Boccon-Gibod L
Pediatr Pathol Lab Med; 1997; 17(2):233-47. PubMed ID: 9086530
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcomas with primary presentation in the skin.
Schmidt D; Fletcher CD; Harms D
Pathol Res Pract; 1993 May; 189(4):422-7. PubMed ID: 8351244
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.
De Zen L; Sommaggio A; d'Amore ES; Masiero L; di Montezemolo LC; Linari A; Madon E; Dominici C; Bosco S; Bisogno G; Carli M; Ninfo V; Basso G
J Clin Oncol; 1997 Mar; 15(3):1198-205. PubMed ID: 9060564
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.
Kubo K; Naoe T; Utsumi KR; Ishiguro Y; Ueda K; Shiku H; Yamada K
Br J Cancer; 1991 Jun; 63(6):879-84. PubMed ID: 1906291
[TBL] [Abstract][Full Text] [Related]
15. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
Hum Pathol; 1994 Sep; 25(9):900-7. PubMed ID: 8088765
[TBL] [Abstract][Full Text] [Related]
16. N- and c-myc oncogenes in childhood rhabdomyosarcoma.
Dias P; Kumar P; Marsden HB; Gattamaneni HR; Kumar S
J Natl Cancer Inst; 1990 Jan; 82(2):151. PubMed ID: 2294225
[No Abstract] [Full Text] [Related]
17. DNA ploidy as a prognostic factor in rhabdomyosarcoma. Analysis of 35 cases with image cytometry.
Pohar-Marinsek Z; Bracko M; Lavrencak J; Us-Krasovec M
Anal Quant Cytol Histol; 2003 Aug; 25(4):235-42. PubMed ID: 12961831
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study.
Leuschner I; Harms D; Mattke A; Koscielniak E; Treuner J
Am J Surg Pathol; 2001 Jul; 25(7):856-64. PubMed ID: 11420456
[TBL] [Abstract][Full Text] [Related]
19. Identification of the 12q15 amplicon within the homogeneously staining regions in the embryonal rhabdomyosarcoma cell line RMS-YM.
Kakazu N; Yamane H; Miyachi M; Shiwaku K; Hosoi H
Cytogenet Genome Res; 2014; 142(3):167-73. PubMed ID: 24480864
[TBL] [Abstract][Full Text] [Related]
20. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
